E-LIB Suche - Ergebnisse für: Hernando-Calvo, A.

1

Updated Dose Expansion Results of a Phase 1/1b Study of the..:

Hanna, G.J. ; Kaczmar, J. ; Zandberg, D.P....
International Journal of Radiation Oncology*Biology*Physics. 118 (2024) 5 - p. e88 , 2024

Link: https://doi.org/10.1016/..

2

Dynamics of clinical biomarkers as predictors of immunother..:

Hernando-Calvo, A. ; García-Alvarez, A. ; Villacampa, G....
Clinical and Translational Oncology. 23 (2020) 2 - p. 311-317 , 2020

Link: https://doi.org/10.1007/..

3

A Phase II, Open-Label, Randomized Trial of Durvalumab With..:

Hernando-Calvo, Alberto ; Han, Ming ; Ayodele, Olubukola...
Clinical Colorectal Cancer. , 2024

Link: https://doi.org/10.1016/..

4

A systematic review of antibody-drug conjugates and bispeci..:

Jiménez-Labaig, Pablo ; Rullan, Antonio ; Hernando-Calvo, Alberto...
Cancer Treatment Reviews. 128 (2024) - p. 102772 , 2024

Link: https://doi.org/10.1016/..

5

Agnostic drug development revisited:

Hernando-Calvo, Alberto ; Rossi, Alice ; Vieito, Maria..
Cancer Treatment Reviews. 128 (2024) - p. 102747 , 2024

Link: https://doi.org/10.1016/..

6

Impact on costs and outcomes of multi-gene panel testing fo..:

Hernando-Calvo, Alberto ; Nguyen, Paul ; Bedard, Philippe L....
eClinicalMedicine. 69 (2024) - p. 102443 , 2024

Link: https://doi.org/10.1016/..

7

Intratumoral therapies in head and neck squamous cell carci..:

Jiménez-Labaig, Pablo ; Rullan, Antonio ; Braña, Irene...
Cancer Treatment Reviews. 127 (2024) - p. 102746 , 2024

Link: https://doi.org/10.1016/..

8

Nutritional status associates with immunotherapy clinical o..:

Hernando-Calvo, Alberto ; Mirallas, Oriol ; Marmolejo, David...
Oral Oncology. 140 (2023) - p. 106364 , 2023

Link: https://doi.org/10.1016/..

9

A pan-cancer clinical platform to predict immunotherapy out..:

Hernando-Calvo, Alberto ; Vila-Casadesús, Maria ; Bareche, Yacine...
Med. 4 (2023) 10 - p. 710-727.e5 , 2023

Link: https://doi.org/10.1016/..

10

Patient-Centric Approaches for Phase I Combination Trials C..:

Hernando-Calvo, Alberto ; Garralda, Elena
Cancer Discovery. 13 (2023) 8 - p. 1762-1764 , 2023

Link: https://doi.org/10.1158/..

11

A risk stratification model for toxicities in phase 1 immun..:

Hernando-Calvo, Alberto ; Salawu, Abdulazeez ; Chen, Rachel Y....
European Journal of Cancer. 175 (2022) - p. 11-18 , 2022

Link: https://doi.org/10.1016/..

12

Impact of pharmacodynamic biomarkers in immuno-oncology pha..:

Salawu, Abdulazeez ; Hernando-Calvo, Alberto ; Chen, Rachel Y....
European Journal of Cancer. 173 (2022) - p. 167-177 , 2022

Link: https://doi.org/10.1016/..

13

Response to "Analysis of the association between prospectiv..:

Villacampa, Guillermo ; Hernando-Calvo, Alberto ; Berché, Roger...
Cancer Treatment Reviews. 111 (2022) - p. 102465 , 2022

Link: https://doi.org/10.1016/..

14

Phase I prognostic online (PIPO): A web tool to improve pat..:

Matos, Ignacio ; Villacampa, Guillermo ; Hierro, Cinta...
European Journal of Cancer. 155 (2021) - p. 168-178 , 2021

Link: https://doi.org/10.1016/..

15

Novel classes of immunotherapy for breast cancer:

Hernando-Calvo, Alberto ; Cescon, David W. ; Bedard, Philippe L.
Breast Cancer Research and Treatment. 191 (2021) 1 - p. 15-29 , 2021

Link: https://doi.org/10.1007/..